- Home
- LRMR vs QSI Comparison
LRMR vs QSI Comparison
Compare LRMR & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LRMR | QSI |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.0M | 273.7M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | LRMR | QSI |
|---|---|---|
| Price | $4.40 | $0.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $16.29 | $1.00 |
| AVG Volume (30 Days) | ★ 7.1M | 2.9M |
| Earning Date | 04-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $196.35 |
| Revenue Next Year | N/A | $229.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.61 | $0.84 |
| 52 Week High | $6.42 | $3.10 |
Technical Indicators
Market Signals| Indicator | LRMR | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 48.50 | 45.06 |
| Support Level | $3.10 | $0.90 |
| Resistance Level | $5.37 | $1.03 |
| Average True Range (ATR) | 0.63 | 0.07 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 27.98 | 39.38 |
Price Performance
Historical ComparisonAbout LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.